| Financial Year |
March 31 2023 |
| Monetary Funds |
639,282,109.16 |
| Held-for-trading Financial Assets |
2,117,218,248.63 |
| Notes Receivable |
11,657,667.57 |
| Accounts Receivable |
296,765,971.58 |
| Advances to Suppliers |
24,548,535.50 |
| Other Receivables |
47,320,762.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
545,277,091.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
802,826,707.23 |
| Total Current Assets |
4,486,944,254.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,744,462.66 |
| Investment Properties |
-- |
| Fixed Assetes |
1,932,201,778.88 |
| Under-construction Projects |
69,771,039.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
180,796,761.42 |
| R&D expenses |
-- |
| Goodwill |
353,092,799.62 |
| Long-Term Deferred and Prepaid Expenses |
1,624,862.48 |
| Deferred Income Tax Assets |
55,845,868.55 |
| Other Non-Current Assets |
174,750,758.33 |
| Sub-Total of Non-Current Assets |
3,079,945,072.44 |
| Total Assets |
7,566,889,327.28 |
| Short-Term Loans |
187,750,000.00 |
| Trading Financial liabilities |
41,717.09 |
| Notes Payable |
151,019,507.46 |
| Accounts Payable |
309,702,255.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,155,688.32 |
| Taxes Payable |
8,871,601.90 |
| Interest Payable |
74,657.43 |
| Dividend Payable |
70,000,000.00 |
| Other payables |
108,717,395.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,875,977.11 |
| Other Current Liabilities |
12,504,561.18 |
| Sub-Total of Current Liabilities |
964,896,286.90 |
| Long-term Loans |
311,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,225,471.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,951,833.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
371,746,810.68 |
| Total Liabilities |
1,336,643,097.58 |
| Paid-In Capital(Or Share Stock) |
300,006,000.00 |
| Capital Surplus |
1,805,845,546.94 |
| Surplus Reserve |
95,661,783.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,902,798,508.28 |
| Minority Stockholder's Interest |
116,548,913.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,113,697,316.01 |
| Owner's Equity（Stockholder's Equity） |
6,230,246,229.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,566,889,327.28 |
